4.5 Article

Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesis

期刊

JOURNAL OF DERMATOLOGY
卷 -, 期 -, 页码 -

出版社

WILEY
DOI: 10.1111/1346-8138.16854

关键词

alarmin; fibroblasts; Fibrosis; IL-11; STAT3; systemic sclerosis

向作者/读者索取更多资源

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by elevated inflammation, aberrant cytokine expression, and subsequent fibrosis. This study aimed to quantify the serum levels of interleukin-11 (IL-11) in early diffuse SSc patients and investigate its relationship with the alarmin IL-33 in dermal fibroblasts. The results showed that patients with early diffuse SSc had elevated levels of IL-11, particularly in those with interstitial lung disease (ILD). In vitro experiments indicated that IL-11 induced the release of IL-33 in fibroblasts, suggesting its involvement in the inflammatory response and fibrosis.
Systemic sclerosis (SSc) is an autoimmune connective tissue disease in which there is elevated inflammation, aberrant cytokine expression, and subsequent fibrosis. Interleukin-11 (IL-11) is a recently described profibrotic cytokine that can mediate fibrosis in the heart, lungs, and skin and is upregulated by transforming Growth Factor-beta (TGF-beta 1). The objective of this study was to quantify the serum levels of IL-11 in early diffuse SSc patients. Also, if IL-11 could regulate the alarmin IL-33 in dermal fibroblasts was quantified. Early diffuse SSc patient sera was isolated and IL-11 was quantified by specific commercial ELISA compared to healthy control (n = 17). Healthy dermal fibroblasts were cultured in vitro and then serum starved and incubated with or without recombinant IL-11. At specific early and late time points the supernatant was quantified for the alarmin IL-33 by specific ELISA. In early diffuse SSc patients it was demonstrated that they have elevated IL-11 in their sera. In a subgroup of SSc patients with interstitial lung disease (ILD) this elevation was particularly pronounced compared to those devoid of fibrotic lung disease. In vitro incubation of healthy dermal fibroblasts led to a significant induction of IL-33 cytokine release into the cell media. IL-11 is a profibrotic cytokine that is elevated in early diffuse SSc and is particularly elevated in those with ILD. This suggests that IL-11 could be a possible biomarker of ILD in SSc. It was also found that IL-11 led to release of the cytokine alarmin IL-33 in fibroblasts at earlier time points but not late time points, suggesting early stimulation elicits an inflammatory response in the local microenvironment but prolonged stimulation leads to fibrosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据